OP7H:PA:PA-Ossiam Bloomberg USA PAB UCITS ETF - 1A EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 131.7975

Change

+0.11 (+0.08)%

Market Cap

N/A

Volume

155.00

Analyst Target

N/A
Analyst Rating

Sell

ducovest Verdict
Created with Highstock 5.0.6

Neutral

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
OP7H:PA
Relative Returns (From:    To: 2025-03-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.07 (-0.15%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.60 (-0.11%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.79 (-0.21%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.07 (-0.21%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.25 (-0.48%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.65 (+0.15%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.88 (-0.26%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.06 (-0.12%)

USD 7.67B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.56 (-0.66%)

USD 5.54B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.13 (-1.74%)

USD 5.25B

ETFs Containing OP7H:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.25% 25% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.25% 24% F 29% F
Trailing 12 Months  
Capital Gain 6.24% 53% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.24% 50% F 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.26% 55% F 62% D
Dividend Return 9.26% 53% F 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.05% 57% F 77% C+
Risk Adjusted Return 76.89% 52% F 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike